![Yves Cornellier](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Yves Cornellier
Fondateur chez Alethia Biotherapeutics, Inc.
Postes actifs de Yves Cornellier
Sociétés | Poste | Début | Fin |
---|---|---|---|
Alethia Biotherapeutics, Inc.
![]() Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alethia Biotherapeutics, Inc. discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets. The firm focuses on bone loss in acute disorders, invasive carcinomas and on cancer-associated epithelial-to-mesenchymal transition. The company was founded in 2002 by Mario Filion and Yves Cornellier and is headquartered in Montreal, Canada. | Directeur/Membre du Conseil | 01/01/2002 | - |
Directeur Général | 01/01/2002 | - | |
Fondateur | 01/01/2002 | - | |
President | 01/01/2002 | - |
Historique de carrière de Yves Cornellier
Anciens postes connus de Yves Cornellier
Sociétés | Poste | Début | Fin |
---|---|---|---|
Miles Laboratories, Inc.
![]() Miles Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Part of Bayer AG, Miles Laboratories, Inc. manufactures pharmaceutical products. The company is based in Rexdale, Canada. | Corporate Officer/Principal | - | - |
Glaxo Canada, Inc. | Corporate Officer/Principal | - | - |
Abbott Laboratories Ltd.
![]() Abbott Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, Abbott Laboratories Ltd. is a British company that manufactures, develops and sells pharmaceutical and nutritional products. The company is based in Maidenhead, UK and was founded in 1937. | Sales & Marketing | - | - |
THERATECHNOLOGIES INC. | Corporate Officer/Principal | - | - |
LAB International, Inc.
![]() LAB International, Inc. Pharmaceuticals: MajorHealth Technology LAB International (LAB Pharma and LAB Research) is an integrated drug development company. LAB Pharma is focused on the growing multi-billion dollar inhalation market. Its lead product, for the treatment of breakthrough cancer pain, is a fast-acting Fentanyl formulation delivered using the Company's TAIFUN(R) dry powder inhaler platform. Its pipeline also includes therapeutics for asthma, COPD, and growth hormone deficiencies | Corporate Officer/Principal | 01/10/2003 | - |
Seyvika Pharmaceuticals
![]() Seyvika Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Seyvika Pharmaceuticals researches and develops drugs for the treatment of asthma. The company is based in Montréal, Canada. The Canadian company was founded by Yves Cornellier. Seyvika Pharmaceuticals was acquired by LAB International, Inc. on October 02, 2003 for $2.23 million. | Fondateur | 20/07/2009 | - |
9342-8530 QUÉBEC INC. | Directeur/Membre du Conseil | - | - |
Statistiques
Internationale
Canada | 8 |
Royaume-Uni | 2 |
Opérationnelle
Corporate Officer/Principal | 4 |
Director/Board Member | 2 |
Founder | 2 |
Sectorielle
Health Technology | 7 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
9342-8530 QUÉBEC INC. | Health Technology |
THERATECHNOLOGIES INC. | Health Technology |
Entreprise privées | 6 |
---|---|
Alethia Biotherapeutics, Inc.
![]() Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alethia Biotherapeutics, Inc. discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets. The firm focuses on bone loss in acute disorders, invasive carcinomas and on cancer-associated epithelial-to-mesenchymal transition. The company was founded in 2002 by Mario Filion and Yves Cornellier and is headquartered in Montreal, Canada. | Health Technology |
Seyvika Pharmaceuticals
![]() Seyvika Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Seyvika Pharmaceuticals researches and develops drugs for the treatment of asthma. The company is based in Montréal, Canada. The Canadian company was founded by Yves Cornellier. Seyvika Pharmaceuticals was acquired by LAB International, Inc. on October 02, 2003 for $2.23 million. | Commercial Services |
LAB International, Inc.
![]() LAB International, Inc. Pharmaceuticals: MajorHealth Technology LAB International (LAB Pharma and LAB Research) is an integrated drug development company. LAB Pharma is focused on the growing multi-billion dollar inhalation market. Its lead product, for the treatment of breakthrough cancer pain, is a fast-acting Fentanyl formulation delivered using the Company's TAIFUN(R) dry powder inhaler platform. Its pipeline also includes therapeutics for asthma, COPD, and growth hormone deficiencies | Health Technology |
Abbott Laboratories Ltd.
![]() Abbott Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, Abbott Laboratories Ltd. is a British company that manufactures, develops and sells pharmaceutical and nutritional products. The company is based in Maidenhead, UK and was founded in 1937. | Health Technology |
Miles Laboratories, Inc.
![]() Miles Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Part of Bayer AG, Miles Laboratories, Inc. manufactures pharmaceutical products. The company is based in Rexdale, Canada. | Health Technology |
Glaxo Canada, Inc. |
- Bourse
- Insiders
- Yves Cornellier
- Expérience